Drug Trial Radar · NCT02405260
Add Glucokinase Activator to Target A1c
Last checked: Nov 19, 2026Latest source record: Feb 10, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
190
Actual
Start
Mar 2015
Primary completion
Jul 2016
Study completion Sep 2016
Sponsor
- Lead sponsor
- vTv TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Apr 1, 2015
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial is a multi-center, adaptive, randomized, double-blind, placebo- and active- controlled, parallel group, Phase 2 study in subjects with T2DM to evaluate the effect of TTP399 on HbA1c following administration for 6 months.
Conditions
- Diabetes Mellitus, Type 2
Interventions
TTP399 400 mgDrug
once daily
TTP399 800 mgDrug
once daily
Sitagliptin 100 mgDrug
once daily
PlaceboDrug
once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in HbA1c (Glycosylated haemoglobin)Time frame: Day 1 to Day 168
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Mesa, Arizona
Site not named
Tuscon, Arizona
Site not named
Canoga Park, California
Site not named
Huntington Park, California
Site not named
Los Angeles, California
Site not named
West Hills, California
Site not named
Centennial, Colorado
Site not named
Littleton, Colorado
Site not named
Waterbury, Connecticut
Site not named
West Palm Beach, Florida
Site not named
Gurnee, Illinois
Site not named
Evansville, Indiana
Site not named
Rochester, Minnesota
Site not named
Greensboro, North Carolina
Site not named
Moncks Corner, South Carolina
Site not named
San Antonio, Texas
Site not named
San Antonio, Texas
Site not named
Schertz, Texas
Site not named
Norfolk, Virginia
Site not named
Richland, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.